Improving the Automated Diagnosis of Breast Cancer with Mesh Reconstruction of Ultrasound Images Incorporating 3D Mesh Features and a Graph Attention Network

结合三维网格特征和图注意力网络的超声图像网格重建改进乳腺癌自动诊断

阅读:1

Abstract

This study proposes a novel approach for breast tumor classification from ultrasound images into benign and malignant by converting the region of interest (ROI) of a 2D ultrasound image into a 3D representation using the point-e system, allowing for in-depth analysis of underlying characteristics. Instead of relying solely on 2D imaging features, this method extracts 3D mesh features that describe tumor patterns more precisely. Ten informative and medically relevant mesh features are extracted and assessed with two feature selection techniques. Additionally, a feature pattern analysis has been conducted to determine the feature's significance. A feature table with dimensions of 445 × 12 is generated and a graph is constructed, considering the rows as nodes and the relationships among the nodes as edges. The Spearman correlation coefficient method is employed to identify edges between the strongly connected nodes (with a correlation score greater than or equal to 0.7), resulting in a graph containing 56,054 edges and 445 nodes. A graph attention network (GAT) is proposed for the classification task and the model is optimized with an ablation study, resulting in the highest accuracy of 99.34%. The performance of the proposed model is compared with ten machine learning (ML) models and one-dimensional convolutional neural network where the test accuracy of these models ranges from 73 to 91%. Our novel 3D mesh-based approach, coupled with the GAT, yields promising performance for breast tumor classification, outperforming traditional models, and has the potential to reduce time and effort of radiologists providing a reliable diagnostic system.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。